MWA With or Without Furmonertinib for Early-Stage Non-Small Cell Lung Cancer

Clinical trial NCT06969781 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06969781
Sponsor: Shanghai Chest Hospital
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Lung Cancer (NSCLC)

Start date: 2025-05-01
Primary completion: 2028-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.